CLINICAL TRIALS PROFILE FOR LATISSE
✉ Email this page to a colleague
All Clinical Trials for latisse
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01229423 ↗ | Safety and Efficacy of LATISSEĀ® in the Augmentation of Eyelashes of Korean Subjects | Completed | Allergan | Phase 4 | 2009-11-01 | This study will evaluate the safety and efficacy of LATISSEĀ® (bimatoprost 0.03%) in the augmentation of eyelashes in Korean women. |
NCT01387906 ↗ | Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo | Completed | Allergan | Phase 4 | 2011-03-01 | The primary purpose of this study is to assess efficacy and safety of Latisse (bimatoprost .03% ophthalmic solution) applied to the lateral and medial eyebrows. The primary outcome is a increase in overall eyebrow prominence as measured by at least a 1-grade increase on the Global Eyebrow Assessment (GEyA) scale, from baseline to the end of the treatment which will be day 270 period. |
NCT01387906 ↗ | Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo | Completed | Kenneth Beer | Phase 4 | 2011-03-01 | The primary purpose of this study is to assess efficacy and safety of Latisse (bimatoprost .03% ophthalmic solution) applied to the lateral and medial eyebrows. The primary outcome is a increase in overall eyebrow prominence as measured by at least a 1-grade increase on the Global Eyebrow Assessment (GEyA) scale, from baseline to the end of the treatment which will be day 270 period. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for latisse
Condition Name
Clinical Trial Locations for latisse
Trials by Country
Clinical Trial Progress for latisse
Clinical Trial Phase
Clinical Trial Sponsors for latisse
Sponsor Name